大鼠成骨細(xì)胞向神經(jīng)細(xì)胞轉(zhuǎn)化的體外誘導(dǎo)研究
本文選題:成骨細(xì)胞 + 神經(jīng)細(xì)胞 ; 參考:《成都中醫(yī)藥大學(xué)》2006年碩士論文
【摘要】:目的 考察大鼠骨膜中的成骨細(xì)胞經(jīng)漏蘆總黃酮體外誘導(dǎo)后向神經(jīng)細(xì)胞轉(zhuǎn)化的可行性,為臨床中樞和外周神經(jīng)損傷的修復(fù)治療提供新的選擇。 方法 從大鼠脛骨內(nèi)側(cè)獲取骨膜,組織塊培養(yǎng)法得到成骨細(xì)胞,經(jīng)鑒定確認(rèn)后體外純化擴(kuò)增培養(yǎng),然后借助MTT(噻唑藍(lán))比色法了解漏蘆總黃酮對(duì)體外培養(yǎng)成骨細(xì)胞生長(zhǎng)的影響,選出合適的誘導(dǎo)濃度,分別加入0.0613%漏蘆總黃酮和2%二甲基亞砜(DMSO)進(jìn)行誘導(dǎo),于誘導(dǎo)24h、48h、72h時(shí)相差顯微鏡下觀察細(xì)胞形態(tài)變化,并于72h時(shí)通過(guò)逆轉(zhuǎn)錄聚合酶鏈反應(yīng)技術(shù)(RT-PCR法)檢測(cè)經(jīng)誘導(dǎo)后的細(xì)胞中是否具有神經(jīng)細(xì)胞特有的神經(jīng)元烯醇化酶(NSE)和特異性膠質(zhì)纖維酸性蛋白(GFAP)的mRNA表達(dá),以此確定神經(jīng)細(xì)胞和神經(jīng)膠質(zhì)細(xì)胞的存在。 結(jié)果 細(xì)胞毒實(shí)驗(yàn)中,在0.09%到1.92%的濃度范圍內(nèi),與空白組比較,各濃度漏蘆總黃酮組活細(xì)胞吸光度值(optical density,OD)明顯減小(P<0.01)。折線圖顯示隨著漏蘆總黃酮濃度加大,OD值呈現(xiàn)持續(xù)上升狀態(tài),對(duì)細(xì)胞的抑制率呈現(xiàn)下降趨勢(shì)。篩選合適誘導(dǎo)濃度(0.0613%)誘導(dǎo)72h后,漏蘆總黃酮組和二甲基亞砜組細(xì)胞形態(tài)均發(fā)生了改變,由原來(lái)的不規(guī)則三角形變?yōu)橥挥|樣生長(zhǎng);RT-PCR法顯示經(jīng)誘導(dǎo)后的細(xì)胞NSE、GFAP的mRNA表達(dá)陽(yáng)性,,且在NSE的mRNA表達(dá)上,漏蘆總黃酮組強(qiáng)于二甲基亞砜組,而在GFAP的mRNA表達(dá)上,二甲基亞砜組強(qiáng)于漏蘆總黃酮組;空白組細(xì)胞在形態(tài)上無(wú)明顯變化,NSE和GFAP的mRNA有極微弱表達(dá)。 結(jié)論 在0.09%到1.92%的濃度范圍內(nèi),漏蘆總黃酮對(duì)體外培養(yǎng)成骨細(xì)胞的生長(zhǎng)有一定抑制作用,但呈現(xiàn)濃度越大抑制率越小的趨勢(shì),考慮不僅與漏蘆總黃酮對(duì)細(xì)胞的毒性作用有關(guān),也與其對(duì)細(xì)胞的誘導(dǎo)作用有關(guān)。成骨細(xì)胞經(jīng)0.0613%漏蘆總黃酮體外誘導(dǎo)后有向神經(jīng)細(xì)胞和神經(jīng)膠質(zhì)細(xì)胞轉(zhuǎn)化的可行性,且更傾向于向神經(jīng)細(xì)胞轉(zhuǎn)化,因此有望成為神經(jīng)種子細(xì)胞的另外一個(gè)來(lái)源。
[Abstract]:Objective to investigate the feasibility of osteoblast in rat periosteum induced by total flavone in vitro and to provide a new choice for the repair and treatment of central and peripheral nerve injury. Methods Osteoblasts were obtained from the medial tibia of rats, and osteoblasts were obtained by tissue mass culture. After identification, the osteoblasts were purified and cultured in vitro. Then the effect of total flavonoids on the growth of osteoblasts cultured in vitro was investigated by MTT colorimetry. The suitable induction concentration was selected and 0.0613% total flavone and 2% DMSO were added respectively. The morphological changes of the cells were observed under a phase-contrast microscope at 24 h, 48 h or 72 h after induction. At 72 h, the mRNA expression of neuronal enolase (NSE) and specific glial fibrillary acidic protein (GFAP) were detected by reverse transcriptase polymerase chain reaction (RT-PCR). This determines the existence of nerve cells and glial cells. Results in the cytotoxicity test, in the range of 0.09% to 1.92%, compared with the blank group, the absorbance of living cells in the total flavone group decreased significantly (P < 0.01). The curve diagram showed that the OD value increased with the increase of total flavonoids concentration, and the inhibition rate of the cells decreased. After 72 hours of induction, the morphology of the cells in the total flavone group and the dimethyl sulfoxide group changed from irregular triangle to synaptic growth. RT-PCR showed that the mRNA expression of NSEG FAP was positive in the induced cells. In the mRNA expression of NSE, the total flavone group was stronger than that in the dimethyl sulfoxide group, while the mRNA expression in the GFAP group was stronger than that in the GFAP group, and the mRNA expression in the blank group had no obvious change in morphology. Conclusion in the range of 0.09% to 1.92%, the total flavone of Leymus chinensis has a certain inhibitory effect on the growth of osteoblasts cultured in vitro, but the higher the concentration is, the smaller the inhibition rate is, which is related not only to the toxicity of the total flavonoids to the cells, but also to the growth of osteoblasts in vitro. It is also related to its induction to cells. Osteoblasts induced by 0.0613% total flavonoids have the feasibility of transforming into nerve cells and glial cells, and are more inclined to convert to nerve cells, so it is expected to be another source of neural seed cells.
【學(xué)位授予單位】:成都中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2006
【分類號(hào)】:R329
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 劉景臣,趙剛,袁紹輝;人參皂甙對(duì)急性脊髓損傷貓脊髓組織及血中MDA含量的影響[J];白求恩醫(yī)科大學(xué)學(xué)報(bào);2000年04期
2 郭麗,孟洪琪,范洪學(xué)*;向神經(jīng)細(xì)胞分化的骨髓間充質(zhì)干細(xì)胞在中樞神經(jīng)系統(tǒng)疾病治療中的應(yīng)用[J];吉林大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2003年06期
3 胡曉梅,何洪陽(yáng),鄭重,許利平,楊松濤;加味補(bǔ)陽(yáng)還五湯對(duì)實(shí)驗(yàn)性損傷脊髓軸漿運(yùn)輸?shù)谋Wo(hù)作用[J];成都中醫(yī)藥大學(xué)學(xué)報(bào);2001年01期
4 李鋼;神經(jīng)干細(xì)胞的來(lái)源[J];中華神經(jīng)醫(yī)學(xué)雜志;2003年05期
5 劉金保,董曉先,董燕湘,何慧華,董偉華,梁仲培,肖慶忠;當(dāng)歸誘導(dǎo)骨髓間充質(zhì)干細(xì)胞分化為神經(jīng)元樣細(xì)胞[J];廣東醫(yī)學(xué);2003年05期
6 鄭漢巧,歐陽(yáng)靜萍,余峰,黃衛(wèi)華,李銀萍,吳珂,龐代文;脂肪組織干細(xì)胞分化為神經(jīng)元樣細(xì)胞研究[J];武漢大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2003年04期
7 黃紅云,王洪美,修波,王銳,盧明,陳琳,亓樹(shù)彬陳林,張澤華,武海青,茍成青,程建鐸,陸曉白,劉宗惠;嗅鞘細(xì)胞移植治療脊髓損傷臨床試驗(yàn)的初步報(bào)告[J];海軍總醫(yī)院學(xué)報(bào);2002年01期
8 楊立業(yè),鄭佳坤,劉相名,惠國(guó)楨,費(fèi)儉,郭禮和;脂肪組織來(lái)源的基質(zhì)細(xì)胞向神經(jīng)元樣細(xì)胞分化[J];四川大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2003年03期
9 付小兵,李建福,盛志勇;對(duì)細(xì)胞逆分化現(xiàn)象的再認(rèn)識(shí)[J];解放軍醫(yī)學(xué)雜志;2003年07期
10 撒亞蓮,李海標(biāo);川芎嗪誘導(dǎo)大鼠骨髓間質(zhì)干細(xì)胞分化為神經(jīng)元樣細(xì)胞的研究[J];解剖學(xué)報(bào);2003年05期
本文編號(hào):1809622
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/1809622.html